Company Registry

Hafion LLC
Profile last edited on: 8/18/2020

Vaccines to protect against bacterial pathogens responsible for significant morbidity and mortality in children
Year Founded
First SBIR Year
Latest SBIR Award
Program Status


Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

4950 Research Park Way
Lawrence, KS 66047
   (785) 764-2296
Multiple Locations:   
Congressional District:   02
County:   Douglas

Public Profile

Hafion is start-up coming out of University of Kansas company organized around completing proof of concept and more for vaccines based on basic research performed in the KU labs. An initial area of focus is Whooping cough (pertussis), a once presumed conquered disease, that is re-emerging because the vaccine is not effective at preventing infection. This acellular vaccine (aP) only stops symptoms and protection is short-lived. A Kaiser Permanente Vaccine Study published in Pediatrics (Feb 2106) found that just three years after vaccination with the aP vaccine and booster, teenagers had lost virtually all of the vaccine’s protection, and more than 90% were susceptible to infection. The resurgence of pertussis due to the ineffective aP is resulting in infants and toddlers not only contracting the disease but dying from the side-effects of the severe whooping cough. The Hafion pertussis vaccine prevents infection, not just the symptoms. The formulation is a simple, 3-4 component vaccine requiring a single administration.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
Less than .5M
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Key People / Management

  Wendy Picking -- President

  Shuang Cai --

  Laird Forrest -- CSO

  Melody Forrest -- CFO

  Erik Naylor --

  Sean K Whittier --

SBIR firms in the news

There are no news available.